Respiratory viruses in older adults, the systemic consequences of infection, and the case for expanding vaccination programs as a health system imperative.

How trust and mistrust shape vaccination decisions in marginalized religious communities and practical approaches to sharing responsibility for community health.

How maternal and infant immunization programs for RSV can be integrated, real-world evidence from Ireland and Europe and the importance of global equity in access to prevention.

Community engagement approaches to improving health, the key barriers to successful engagement and a framework for building trust and equity in underserved communities.

The structural and behavioral barriers to vaccination in underserved communities and how health systems must be redesigned around people's lived realities.

Evidence on the widening inequalities in childhood vaccination uptake in the UK, linking the declining coverage to rising child poverty and cuts to preventive services.

Barnardo's RSV public health campaign, showing how a culturally competent, community-led approach can reach underserved families and reduce health inequalities.

The three systemic failures that prevent vaccination programs from achieving equity, what overcoming them requires.

The burden of RSV, influenza, and SARS-CoV-2, the systemic complications these viruses trigger, and the case for lifelong integrated immunization strategies.

Economic and societal case for lifecourse prevention and the role of vaccination in protecting older adults from infectious diseases.

What Health Technology Assessment means for vaccines, and why getting it right matters for new vaccines to reach patients equitably and efficiently across EU.

Embedding vaccination within non-communicable disease management for aging populations, reducing health system strain, and delivering economic returns.

The systemic consequences of influenza and pneumococcal infections in older adults and evidence that vaccination must be positioned as a cornerstone of healthy aging policy.

Review of the available strategies for pediatric RSV prevention, presenting real-world evidence from across Europe and arguing that all infants need protection.

The drivers of vaccine hesitancy and declining confidence globally, evidence on the role of trust, and institutional credibility in shaping vaccination decisions.

Strategies to improve immunization access in underserved communities, addressing social determinants of health and healthcare system barriers.

Diagnostic uncertainty in respiratory infections and evidence-based approaches for antibiotic stewardship to combat resistance.

Data-driven analysis of RSV hospitalization burdens across age groups, seasonal patterns and system-level challenges for healthcare capacity planning.

How pharmacists can transform vaccination accessibility in underserved communities, practical models to integrate pharmacy-based immunization into healthcare systems.

Practical solutions to implement WHO's Immunization Agenda 2030 for older adults, system challenges and policy frameworks to improve coverage.

Barriers to adult vaccination and strategies to increase immunization rates through healthcare access, education, and policy frameworks.

How inadequate vaccination in older adults exacerbates chronic conditions, increases hospitalization risks, and impacts healthcare systems and quality of life.

Current respiratory syncytial virus epidemiology and breakthrough preventive options, including vaccines and monoclonal antibodies across the lifecourse.

Lifelong individual and public health impacts of missed childhood immunizations, with insights on preventing outbreaks and protecting community immunity.

System-level adaptations to reach populations with low vaccination coverage, innovative models that overcome geographical, cultural and socioeconomic barriers.

How civil society organizations and community leaders can address vaccination gaps, build trust, and implement sustainable immunization programs in diverse communities.

Clinical analysis of severe bronchiolitis and pneumonia cases requiring intensive care intervention, examining treatment protocols, long-term consequences, and strategies to improve patient outcomes.

Resource utilization and clinical management of bronchiolitis and pneumonia in community settings, with practical insights for optimizing primary care response.

The burden of bronchiolitis and pneumonia on families, emotional, financial, and social implications alongside clinical consequences.

How false information limits equitable vaccine access, evidence-based approaches to misinformation and community trust in immunization programs.

Strategic approaches to technological and health literacy challenges preventing older adults from accessing vaccines.

Approaches to protect infants from RSV, recent advancements in maternal immunization and passive antibody protection strategies for newborns.

RSV and shingles vaccination for adults, clinical evidence, implementation, and the impact on reducing disease burden in older populations.

Spain's RSV immunization program for infants, implementation strategies, healthcare system integration, and early outcome data.

Personal accounts from parents of children affected by RSV, highlighting the critical need for public awareness and prevention strategies.

Maternal vaccination as a fundamental component of lifecourse immunization, dual protection benefits for mothers and infants and implementation considerations.

Presentation from the 8th Lifecourse Summit comparing different RSV prevention approaches, analyzing the antibody response patterns and duration of protection offered by vaccines and monoclonal antibodies across various populations.

Expert insights on implementing effective RSV immunization programs, addressing implementation challenges, healthcare system integration, and strategies to maximize public health impact across populations.

Vaccination strategies for older adults within a lifecourse framework, age-specific needs, barriers to access, and policy recommendations.

How community-driven vaccination demand supports lifecourse immunization programs, with strategies for public engagement and advocacy.

How civil society organizations can advocate for vaccination programs, building community support and influencing policy decisions across age groups.

How social networks shape vaccine attitudes, and strategies for leveraging these platforms to counteract misinformation and promote evidence-based vaccine decisions.

The impact of RSV on older populations and the clinical rationale for targeted prevention strategies to reduce hospitalization and mortality.

Multiple viral pathogen detection in acute bronchiolitis and clinical implications and management challenges when RSV occurs alongside other respiratory viruses.

Overview of the global RSV prevention pipeline, detailing vaccine candidates and monoclonal antibody developments across different populations.

WHO's global strategy to defeat meningitis, current progress and feasibility of eventual eradication of meningococcal disease through coordinated international efforts.

How nurses can address vaccination hesitancy, featuring evidence-based communication strategies and practical approaches to build patient confidence.

How RSV affects healthy pediatric populations, infection rates, clinical outcomes, and the impact on children without underlying health conditions.

Strategies to improve vaccination coverage among European teenagers, unique challenges and evidence-based approaches to adolescent-focused immunization.

The knowledge gap around RSV infections, effective communication strategies for healthcare professionals and increased awareness and prevention.

Lessons from emerging infectious disease threats to RSV prevention strategies and global health security approaches for more effective respiratory virus control.

RSV monitoring systems in the Netherlands & Europe, methodologies, data integration, and implications for public health response strategies.

RSV immunization approaches, clinical trial data and the potential impact of new maternal vaccines and monoclonal antibodies for infant protection.

Approaches to improve childhood influenza vaccination, barriers to uptake and innovative strategies to protect children from seasonal flu.

Multidisciplinary perspectives on universal RSV protection for all infants, clinical evidence, public health impacts, and implementation for comprehensive coverage.

Challenges in achieving meningococcal disease prevention, access issues, policy gaps, and interventions to improve protection.

Aapproaches to increase vaccine confidence among pregnant women, communication strategies to improve maternal and infant protection through immunization.

Data-driven analysis of how vaccination across all life stages reduces hospital admissions, healthcare resource utilization, and system-wide economic burden.

Evidence-based analysis of historical influenza data, extracting key insights on virus patterns, vaccination effectiveness, and preparedness strategies to improve responses to future seasonal outbreaks.

Practices from implementing a massive-scale national immunization program, logistical challenges, success factors, and transferable strategies.

Presentation from the 7th Lifecourse Summit exploring strategies to improve vaccine acceptance among at-risk older adults, addressing hesitancy factors and communication approaches specific to senior populations.

Strategies to improve influenza immunization coverage across all European age groups, policy recommendations, cross-border initiatives, and practical approaches.

Presentation from the 7th Lifecourse Summit featuring a parent's first-hand account of their family's experience with RSV infection, highlighting the emotional, financial, and long-term impacts of respiratory syncytial virus.

Analysis of how vaccination across all life stages generates significant population-level health improvements, direct protection, herd immunity, and broader societal impacts.

The determinants of vaccination acceptance among healthcare professionals, motivational factors, barriers, and effective strategies to improve immunization rates.

Critical examination of RSV infection patterns, knowledge gaps in community-based disease burden and transmission dynamics that impact public health response.

Consistent vaccination recommendations for immunocompromised adults, current guideline variations and strategies for standardization across healthcare systems.

Online vaccination misinformation after the pandemic, with evidence-based approaches to maintain vaccine confidence and counter false narratives.

Disruptions to childhood vaccination programs, coverage declines, contributing factors, and strategies to recover missed immunizations and strengthen systems.

Preventive strategies for RSV-associated respiratory infections in infants, effectiveness and implementation considerations across healthcare settings.

Presentation from the 7th Lifecourse Summit providing strategies for effectively conveying the public health and economic impact of RSV to policy decision-makers, emphasizing data presentation and policy advocacy approaches.

Sustainable vaccination programs for older adults, with focus on accessibility, communication strategies, and healthcare system integration to improve senior protection.

Scientific examination of antibody response and duration of protection against RSV using various preventive approaches

How the COVID vaccination campaign's emphasis on social responsibility may create opportunities to reframe all immunization as a collective health measure.

Novel strategies for influenza vaccination impact, alternative delivery methods, adjuvanted vaccines, and targeted approaches for enhanced protection.

The PPV23 pneumococcal vaccination program for older adults in the Netherlands, highlighting coverage rates, challenges, and early impact data.

HCPs COVID vaccination requirements and their potential application to other vaccines, ethical considerations, policy implications, and workforce impacts.

RSV-associated hospitalizations and their impact on healthcare resources, staffing, costs, and system capacity, with implications for prevention and management policies.

RSV's burden in private healthcare settings, resource utilization, clinical management challenges, and system-wide impacts.

RSV bronchiolitis management, emerging prevention and treatment approaches, including promising vaccines and monoclonal antibody therapies.

Social media sentiment to gauge public vaccine confidence, with insights on monitoring trends, identifying misinformation, and targeted communication strategies.

Predictors of parental acceptance or refusal of COVID-19 vaccines for young children, key demographic, social, and psychological factors influencing vaccination decisions.

Shifting vaccine attitudes during and after the COVID-19, changes in public perception, hesitancy patterns, and implications for future immunization campaigns.

Strategic approaches to engage with the three main vaccine attitude segments (believers, indifferent, opposed), changing perceptions and tailoring communication strategies.

Strategies to maximize the effectiveness of influenza vaccines in older adults, immune senescence challenges and vaccination timing to improve protection outcomes.

Strategies to renew public and healthcare professional focus on meningococcal disease prevention, awareness challenges and communication approaches after COVID-19.

Strategies to communicate the importance of protection against all meningococcal strains across diverse populations and age groups.

Lessons from COVID-19 vaccination campaigns to advance lifecourse immunization programs, leveraging pandemic experiences to strengthen vaccination.

HPV and COVID-19 vaccination in adolescents, acceptance patterns, implementation challenges, and strategies to improve uptake.

Examination of how personalized medicine expectations have influenced COVID vaccine hesitancy, creating new concerns about standardized vaccination approaches in an era of individualized treatments.

Innovative approach to developing health education materials with student involvement, creating age-appropriate and engaging resources

How RSV infections strain healthcare resources, insights on hospitalization patterns, cost implications, and strategies to mitigate system burden through prevention.

How vaccination strategies across all life stages contribute to healthcare system sustainability through reduced disease burden and economic benefits.

The dangers of students mistaking meningitis symptoms for COVID-19, and strategies to improve awareness and early intervention on campuses.

Vaccine education needs for healthcare practitioners, hesitancy factors and evidence-based strategies to build vaccine confidence in clinical settings.

WHO's strategic roadmap to defeat meningitis globally by 2030, key priorities, implementation challenges, and collaborative approaches to prevention and control.

How comprehensive vaccination strategies reduce hospitalization rates, ambulatory care needs, and medical interventions during the COVID-19 pandemic and beyond.

Pandemic disruptions to meningococcal prevention programs, changing disease patterns, surveillance challenges, and strategies to maintain immunization services.

How experiences from disease outbreaks can strengthen health system resilience, insights on adaptive infrastructure, emergency preparedness, and long-term capacity building.

How the COVID-19 pandemic accelerated the spread of health misinformation, information ecosystem changes and effective counter-strategies for public health communicators.